Codexis (CDXS): 10% owner bought ~$73K
Opaleye Management Inc., 10% owner at Codexis, bought ~$73K of Codexis shares.
- ~$73K
- Approx. value · 25K sh @ $2.91
- 8.54M
- Holds after · shares reported
- Traded
- Oct 25, 2024
- Filed
- Oct 28, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 25, 2024 · this disclosureInsider10% owner purchased ~$73K of CDXS shares in the open market
What came next
- Dec 30, 2024Insider10% owner purchased ~$164K of CDXS shares in the open market
- Dec 31, 2024Insider10% owner purchased ~$47K of CDXS shares in the open market
- Jan 30, 2025Insider10% owner purchased ~$90K of CDXS shares in the open market
- Jan 31, 2025Insider10% owner purchased ~$193K of CDXS shares in the open market
- Feb 10, 2025Insider10% owner purchased ~$94K of CDXS shares in the open market
- Feb 11, 2025Insider10% owner purchased ~$51K of CDXS shares in the open market
- Feb 12, 2025Insider10% owner purchased ~$60K of CDXS shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Codexis
For Codexis, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CDXS page.
Other recent filings by Opaleye Management Inc., 10% owner
- SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
- SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
- SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
- SEC Form 4 at Grace Therapeutics (GRCE)Oct 26, 2026
- SEC Form 4 at Alpha Cognition (ACOG)Oct 26, 2026
The full history of Opaleye Management Inc., 10% owner is on the profile page.
How this filing works
Explore the data
Other disclosures at Codexis
- SEC Form 4Nov 10, 2026
- SEC Schedule 13GNov 6, 2026
- SEC Form 4Oct 14, 2026
- SEC Form 4Oct 14, 2026
- SEC Form 144Oct 13, 2026
- SEC Form 144Oct 13, 2026
Everything OQRO holds on this company is on its CDXS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
